2021
DOI: 10.1016/j.meegid.2021.104910
|View full text |Cite
|
Sign up to set email alerts
|

A Sanger-based approach for scaling up screening of SARS-CoV-2 variants of interest and concern

Abstract: The global spread of new SARS-CoV-2 variants of concern underscore an urgent need of simple deployed molecular tools that can differentiate these lineages. Several tools and protocols have been shared since the beginning of the COVID-19 pandemic, but they need to be timely adapted to cope with SARS-CoV-2 evolution. Although whole-genome sequencing (WGS) of the virus genetic material has been widely used, it still presents practical difficulties such as high cost, shortage of available reagents in the global ma… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
37
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(38 citation statements)
references
References 13 publications
(4 reference statements)
0
37
0
1
Order By: Relevance
“…The ethics approval was issued on June 12, 2020. SARS-CoV-2 VOCs and VOIs included in this study were isolated from symptomatic patients (Ct value < 25, using E gene as target on RT-qPCR—Kit Molecular SARS-CoV-2 E/RP Bio-Manguinhos Fiocruz), in the State Pernambuco, Northeast Brazil ( Bezerra et al, 2021 ; Supplementary Table 3 ). The study was approved by the local Human Research Ethics Committee (CAAE: 32333120.4.0000.5190).…”
Section: Methodsmentioning
confidence: 99%
“…The ethics approval was issued on June 12, 2020. SARS-CoV-2 VOCs and VOIs included in this study were isolated from symptomatic patients (Ct value < 25, using E gene as target on RT-qPCR—Kit Molecular SARS-CoV-2 E/RP Bio-Manguinhos Fiocruz), in the State Pernambuco, Northeast Brazil ( Bezerra et al, 2021 ; Supplementary Table 3 ). The study was approved by the local Human Research Ethics Committee (CAAE: 32333120.4.0000.5190).…”
Section: Methodsmentioning
confidence: 99%
“…In contrast to WGS, amplicon deep sequencing focuses on a specific gene or genomic region, providing a greater sequencing depth and coverage while reducing costs and data burden. Sanger-based approaches have been previously employed ( Bezerra et al, 2021 , Goes et al, 2021 ). These are either focused on a small window in the S gene, and hence missing relevant SNPs flanking said region, or target SNPs prevalent to specific VOC/VOIs.…”
Section: Discussionmentioning
confidence: 99%
“…It should be mentioned that in the case of a large number of samples, the costs of NGS sequencing are dramatically reduced and can be competitive with Sanger sequencing. In these cases, the use of this latter method should be limited to confirmation of mutations within the S gene when a limited number of cases are analysed [ 17 ].…”
Section: Discussionmentioning
confidence: 99%